✦ LIBER ✦

Striatal Dopaminergic and Serotonergic Markers in Human Heroin Users

✍ Scribed by Stephen J Kish; Kathryn S Kalasinsky; Peter Derkach; Gregory A Schmunk; Mark Guttman; Lee Ang; Vernard Adams; Yoshiaki Furukawa; John W Haycock

Book ID: 114280736
Publisher: Nature Publishing Group
Year: 2001
Tongue: English
Weight: 140 KB
Volume: 24
Category: Article
ISSN: 1470-634X
DOI: 10.1016/s0893-133x(00)00209-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Striatal dopamine nerve terminal markers

Striatal dopamine nerve terminal markers in human, chronic methamphetamine users

✍ Wilson, Julie M.; Kalasinsky, Kathryn S.; Levey, Allan I.; Bergeron, Catherine; 📂 Article 📅 1996 🏛 Nature Publishing Group 🌐 English ⚖ 547 KB

In vivo effects of aripiprazole on corti

In vivo effects of aripiprazole on cortical and striatal dopaminergic and serotonergic function

✍ Shaun Jordan; Vuk Koprivica; Robert Dunn; Katsura Tottori; Tetsuro Kikuchi; C.An 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 831 KB

Naltrexone administration during the pre

Naltrexone administration during the preweanling period affects striatal and hypothalamic serotonergic systems, but not midbrain serotonergic or striatal dopaminergic systems in the adult rat

✍ María Paz Viveros; Carlos de Cabo; María Isabel Colado; María Isabel Martín 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 394 KB

Interaction between the serotonergic, do

Interaction between the serotonergic, dopaminergic, and glutamatergic systems in fenfluramine-induced Fos expression in striatal neurons

✍ M.J. Guerra; I. Liste; J.L. Labandeira-Garcia 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 633 KB

Fenfluramine (FE) is a halogenated amphetamine derivative used in the treatment of obesity and thought to induce serotonin (5-HT) release from nerve terminals and to reduce re-uptake. However, other pathways may also be involved. In this work, the effects of FE on the major striatal afferent systems

Immunohistochemical investigation of dop

Immunohistochemical investigation of dopaminergic terminal markers and caspase-3 activation in the striatum of human methamphetamine users

✍ Osamu Kitamura; Itsuo Tokunaga; Takako Gotohda; Shin-ichi Kubo 📂 Article 📅 2006 🏛 Springer-Verlag 🌐 German ⚖ 222 KB

Striatal dopaminergic markers in dementi

Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: rostrocaudal distribution

✍ Piggott, M. A. 📂 Article 📅 1999 🏛 Oxford University Press 🌐 English ⚖ 718 KB